SCHEMBL105486

Kakonein is a lipid of Polyketides (PK) class. Kakonein is associated with abnormalities such as Fatty Liver, Chronic liver disease, Morphologically altered structure, Hypertensive disease and Cardiovascular Diseases. The involved functions are known as protein expression, Extravasation, Liver damage, mRNA Expression and cell activation. Kakonein often locates in Body tissue, Hepatic, Microvilli, Cytoplasm and Membrane. The associated genes with Kakonein are TJP1 gene, CD14 gene, iberiotoxin, AT-Rich Interactive Domain-Containing Protein 1A and NKS1 gene. The related lipids are dehydrosoyasaponin I and Steroids. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of SCHEMBL105486, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with SCHEMBL105486?

SCHEMBL105486 is suspected in Chronic liver disease, Hypertensive disease, Cardiovascular Diseases, Myocardial Infarction, Cerebrovascular accident, Fatty Liver and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with SCHEMBL105486

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Lead Poisoning D007855 4 associated lipids
Adenocarcinoma D000230 166 associated lipids
Burns D002056 34 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Fatty Liver D005234 48 associated lipids
Per page 10 20 50 | Total 43

PubChem Associated disorders and diseases

What pathways are associated with SCHEMBL105486

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with SCHEMBL105486?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with SCHEMBL105486?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with SCHEMBL105486?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with SCHEMBL105486?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with SCHEMBL105486?

Knock-out

Knock-out are used in the study 'MATE2 mediates vacuolar sequestration of flavonoid glycosides and glycoside malonates in Medicago truncatula.' (Zhao J et al., 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with SCHEMBL105486

Download all related citations
Per page 10 20 50 100 | Total 919
Authors Title Published Journal PubMed Link
Luo CF et al. Metabolic profile of puerarin in rats after intragastric administration of puerarin solid lipid nanoparticles. 2013 Int J Nanomedicine pmid:23486407
Cao L et al. Pharmacokinetics of puerarin in pregnant rats at different stages of gestation after oral administration. 2013 Fitoterapia pmid:23500385
Guo C et al. Anti-fibrotic effects of puerarin on CCl4-induced hepatic fibrosis in rats possibly through the regulation of PPAR-γ expression and inhibition of PI3K/Akt pathway. 2013 Food Chem. Toxicol. pmid:23500774
Liu CM et al. Protective effect of puerarin on lead-induced mouse cognitive impairment via altering activities of acetyl cholinesterase, monoamine oxidase and nitric oxide synthase. 2013 Environ. Toxicol. Pharmacol. pmid:23501611
Cheng M et al. Puerarin accelerates re-endothelialization in a carotid arterial injury model: impact on vasodilator concentration and vascular cell functions. 2013 J. Cardiovasc. Pharmacol. pmid:23792702
Xu L et al. Puerarin, isolated from Pueraria lobata (Willd.), protects against hepatotoxicity via specific inhibition of the TGF-β1/Smad signaling pathway, thereby leading to anti-fibrotic effect. 2013 Phytomedicine pmid:23856441
Li R et al. Puerarin attenuates neuronal degeneration and blocks oxidative stress to elicit a neuroprotective effect on substantia nigra injury in 6-OHDA-lesioned rats. 2013 Brain Res. pmid:23603411
Li N et al. Determination of glibenclamide and puerarin in rat plasma by UPLC-MS/MS: application to their pharmacokinetic interaction study. 2013 Talanta pmid:23597896
Wang Y et al. Puerarin stimulates proliferation and differentiation and protects against cell death in human osteoblastic MG-63 cells via ER-dependent MEK/ERK and PI3K/Akt activation. 2013 Phytomedicine pmid:23639192
Chen F et al. Puerarin-induced immune hemolytic anemia. 2013 Int. J. Hematol. pmid:23661032
Cao WL et al. [Effect of puerarin on hemorheology and pulmonary pressure in rat pneumo-cardiac disease]. 2013 Zhongguo Ying Yong Sheng Li Xue Za Zhi pmid:23662397
Huang ZG et al. [Effect of puerarin combined with felodipine on mRNA and protein expression of apelin and APJ in renovascular hypertensive rat]. 2013 Zhongguo Zhong Yao Za Zhi pmid:23668014
Zhang Y et al. Effects of puerarin on cholinergic enzymes in the brain of ovariectomized guinea pigs. 2013 Int. J. Neurosci. pmid:23668913
Chen X et al. Puerarin improves metabolic function leading to hepatoprotective effects in chronic alcohol-induced liver injury in rats. 2013 Phytomedicine pmid:23669266
Wang Q et al. Magnetic solid-phase extraction and determination of puerarin in rat plasma using C(18)-functionalized magnetic silica nanoparticles by high performance liquid chromatography. 2013 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:23246846
Peng JH et al. Puerarin ameliorates experimental alcoholic liver injury by inhibition of endotoxin gut leakage, Kupffer cell activation, and endotoxin receptors expression. 2013 J. Pharmacol. Exp. Ther. pmid:23277536
Nakamura K et al. Enzymatic cleavage of the C-glucosidic bond of puerarin by three proteins, Mn(2+), and oxidized form of nicotinamide adenine dinucleotide. 2013 Biol. Pharm. Bull. pmid:23328408
Tao HQ et al. HP-β-CD-PLGA nanoparticles improve the penetration and bioavailability of puerarin and enhance the therapeutic effects on brain ischemia-reperfusion injury in rats. 2013 Naunyn Schmiedebergs Arch. Pharmacol. pmid:23192284
Yin R et al. UFLC-MS/MS method for simultaneous determination of luteolin-7-O-gentiobioside, luteolin-7-O-β-D-glucoside and luteolin-7-O-β-D-glucuronide in beagle dog plasma and its application to a pharmacokinetic study after administration of traditional Chinese medicinal preparation: Kudiezi injection. 2013 J Pharm Biomed Anal pmid:23146236
Li R et al. Puerarin mediates hepatoprotection against CCl4-induced hepatic fibrosis rats through attenuation of inflammation response and amelioration of metabolic function. 2013 Food Chem. Toxicol. pmid:23146695
Zou Y et al. Protective effect of puerarin against beta-amyloid-induced oxidative stress in neuronal cultures from rat hippocampus: involvement of the GSK-3β/Nrf2 signaling pathway. 2013 Free Radic. Res. pmid:23088308
Wang Y et al. In vitro and in vivo anticancer activity of a novel puerarin nanosuspension against colon cancer, with high efficacy and low toxicity. 2013 Int J Pharm pmid:23089583
Zhang J et al. Effects of puerarin on the inflammatory role of burn-related procedural pain mediated by P2X(7) receptors. 2013 Burns pmid:23044342
Bai S et al. Effects of felodipine combined with puerarin on ACE2-Ang (1-7)-Mas axis in renovascular hypertensive rat. 2013 Regul. Pept. pmid:23523569
Li R et al. Puerarin attenuates neuronal degeneration in the substantia nigra of 6-OHDA-lesioned rats through regulating BDNF expression and activating the Nrf2/ARE signaling pathway. 2013 Brain Res. pmid:23747813
Li R et al. Puerarin, isolated from Kudzu root (Willd.), attenuates hepatocellular cytotoxicity and regulates the GSK-3β/NF-κB pathway for exerting the hepatoprotection against chronic alcohol-induced liver injury in rats. 2013 Int. Immunopharmacol. pmid:23751897
Liu X et al. Pharmacokinetic comparisons of puerarin, daidzin and the glucuronide metabolite of puerarin after administration of total flavonoid from Gegen alone and total flavonoid from Gegen combined with total saponin from Sanqi in rats under different physiological states. 2013 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:23774247
Wong KH et al. Differentiation of Pueraria lobata and Pueraria thomsonii using partial least square discriminant analysis (PLS-DA). 2013 J Pharm Biomed Anal pmid:23777642
Xia DZ et al. Hepatoprotective activity of puerarin against carbon tetrachloride-induced injuries in rats: a randomized controlled trial. 2013 Food Chem. Toxicol. pmid:23764356
Wang L et al. Protective effects of puerarin on experimental chronic lead nephrotoxicity in immature female rats. 2013 Hum Exp Toxicol pmid:23315276
Wu K et al. Anti-diabetic effects of puerarin, isolated from Pueraria lobata (Willd.), on streptozotocin-diabetogenic mice through promoting insulin expression and ameliorating metabolic function. 2013 Food Chem. Toxicol. pmid:23927877
Wu X et al. Isolation, identification and pharmacokinetic analysis of fructosyl puerarins from enzymatic glycosylation. 2013 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:23948238
Cheng Y et al. Effects of puerarin on cardiac differentiation and ventricular specialization of murine embryonic stem cells. 2013 Cell. Physiol. Biochem. pmid:24080853
Zhao LX et al. The permeability of puerarin loaded poly(butylcyanoacrylate) nanoparticles coated with polysorbate 80 on the blood-brain barrier and its protective effect against cerebral ischemia/reperfusion injury. 2013 Biol. Pharm. Bull. pmid:23902970
Ji M et al. Puerarin suppresses proliferation of endometriotic stromal cells in part via differential recruitment of nuclear receptor coregulators to estrogen receptor-α. 2013 J. Steroid Biochem. Mol. Biol. pmid:23907019
Tu L et al. Effects of particle size on the pharmacokinetics of puerarin nanocrystals and microcrystals after oral administration to rat. 2013 Int J Pharm pmid:24120729
Cui YH et al. [Adsorption and isolation of macroporous resin for three isoflavonoids from puerariae lobatae radix]. 2013 Zhong Yao Cai pmid:24134015
Singh AK et al. Anti-inflammatory potency of nano-formulated puerarin and curcumin in rats subjected to the lipopolysaccharide-induced inflammation. 2013 J Med Food pmid:24138167
Jiang L et al. Simultaneous determination of gastrodin and puerarin in rat plasma by HPLC and the application to their interaction on pharmacokinetics. 2013 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:23314488
Liu AC et al. LC-MS/MS method for the determination of a new puerarin derivative and its application in pharmacokinetic studies in rats. 2013 Chin J Nat Med pmid:24359785
Zhu H et al. Effect of puerarin on matrix metalloproteinase-2 in human fetal scleral fibroblasts treated with low frequency electromagnetic fields. 2013 J Tradit Chin Med pmid:24660593
Tang TT et al. Mechanisms of microemulsion enhancing the oral bioavailability of puerarin: comparison between oil-in-water and water-in-oil microemulsions using the single-pass intestinal perfusion method and a chylomicron flow blocking approach. 2013 Int J Nanomedicine pmid:24277986
Ji O et al. [Effect of flavonoids of puerarin on the proliferation and apoptosis of retinoic acid resistant acute promyelocytic leukemia cell line NB4-R1 cells]. 2013 Zhonghua Xue Ye Xue Za Zhi pmid:23688762
Wu Y et al. Optimisation of ultrasound-assisted extraction of puerarin and total isoflavones from Puerariae Lobatae Radix (Pueraria lobata (Wild.) Ohwi) with response surface methodology. 2012 Sep-Oct Phytochem Anal pmid:22259187
Penetar DM et al. The isoflavone puerarin reduces alcohol intake in heavy drinkers: a pilot study. 2012 Drug Alcohol Depend pmid:22578529
Kim J et al. Puerarin inhibits the retinal pericyte apoptosis induced by advanced glycation end products in vitro and in vivo by inhibiting NADPH oxidase-related oxidative stress. 2012 Free Radic. Biol. Med. pmid:22609359
Han J et al. [Study on 3'-methoxy puerarin to dynamic changes of amino acids in rat brain ischemia-reperfusion]. 2012 Zhongguo Zhong Yao Za Zhi pmid:22792810
Liang J et al. Puerarin inhibits caspase-3 expression in osteoblasts of diabetic rats. 2012 Mol Med Rep pmid:22470138
Song JX et al. Anti-Parkinsonian drug discovery from herbal medicines: what have we got from neurotoxic models? 2012 J Ethnopharmacol pmid:22212501
Deng Y et al. Mechanisms of the cerebral vasodilator actions of isoflavonoids of Gegen on rat isolated basilar artery. 2012 J Ethnopharmacol pmid:22120017